{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:39:58Z","timestamp":1794357598648,"version":"4.9.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hong Kong Research Grant Council Research Impact Fund","award":["R4012-18"],"award-info":[{"award-number":["R4012-18"]}]},{"name":"Chinese University of Hong Kong research accounts","award":["6905134, 2410026, and 3133200"],"award-info":[{"award-number":["6905134, 2410026, and 3133200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic kidney diseases (DKD) is a the most common cause of end-stage kidney disease (ESKD) around the world. Previous studies suggest that urinary podocyte stress biomarker, e.g. podocin:nephrin mRNA ratio, is a surrogate marker of podocyte injury in non-diabetic kidney diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We studied 118 patients with biopsy-proved DKD and 13 non-diabetic controls. Their urinary mRNA levels of nephrin, podocin, and aquaporin-2 (AQP2) were quantified. Renal events, defined as death, dialysis, or 40% reduction in glomerular filtration rate, were determined at 12 months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Urinary podocin:nephrin mRNA ratio of DKD was significantly higher than the control group (<jats:italic>p<\/jats:italic>\u2009=\u20090.0019), while urinary nephrin:AQP2 or podocin:AQP2 ratios were not different between groups. In DKD, urinary podocin:nephrin mRNA ratio correlated with the severity of tubulointerstitial fibrosis (<jats:italic>r<\/jats:italic>\u2009=\u20090.254, <jats:italic>p<\/jats:italic>\u2009=\u20090.006). and was associated with the renal event-free survival in 12 months (unadjusted hazard ratio [HR], 1.523; 95% confidence interval [CI] 1.157\u20132.006; <jats:italic>p<\/jats:italic>\u2009=\u20090.003). After adjusting for clinical and pathological factors, urinary podocin:nephrin mRNA ratio have a trend to predict renal event-free survival (adjusted HR, 1.327; 95%CI 0.980\u20131.797; <jats:italic>p<\/jats:italic>\u2009=\u20090.067), but the result did not reach statistical significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Urinary podocin:nephrin mRNA ratio has a marginal prognostic value in biopsy-proven DKD. Further validation is required for DKD patients without kidney biopsy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03471-8","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:02:20Z","timestamp":1706090540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Lingfeng","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston Wing-Shing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Chun-Kau","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"2","key":"3471_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"CY Jung","year":"2022","unstructured":"Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in Diabetic kidney disease. Diabetes Metab J. 2022;46(2):181\u201397.","journal-title":"Diabetes Metab J"},{"issue":"5","key":"3471_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00125-018-4567-5","volume":"61","author":"HM Colhoun","year":"2018","unstructured":"Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetologia. 2018;61(5):996\u20131011.","journal-title":"Diabetologia"},{"key":"3471_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3389\/fgene.2020.00993","volume":"11","author":"H Ishii","year":"2020","unstructured":"Ishii H, Kaneko S, Yanai K, Aomatsu A, Hirai K, Ookawara S, Ishibashi K, Morishita Y. MicroRNAs in Podocyte Injury in Diabetic Nephropathy. Front Genet. 2020;11:993.","journal-title":"Front Genet"},{"issue":"4","key":"3471_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.semnephrol.2012.06.010","volume":"32","author":"A Tufro","year":"2012","unstructured":"Tufro A, Veron D. VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012;32(4):385\u201393.","journal-title":"Semin Nephrol"},{"issue":"4","key":"3471_CR5","doi-asserted-by":"publisher","first-page":"bvaa029","DOI":"10.1210\/jendso\/bvaa029","volume":"4","author":"I Kravets","year":"2020","unstructured":"Kravets I, Mallipattu SK. The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease. J Endocr Soc. 2020;4(4):bvaa029.","journal-title":"J Endocr Soc"},{"key":"3471_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cca.2021.10.017","volume":"523","author":"L Zeng","year":"2021","unstructured":"Zeng L, Szeto CC. Urinary podocyte markers in kidney diseases. Clin Chim Acta. 2021;523:315\u201324.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"3471_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1681\/ASN.2007121328","volume":"20","author":"Y Sato","year":"2009","unstructured":"Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC. Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol. 2009;20(5):1041\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3471_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/08860221003611737","volume":"32","author":"G Wang","year":"2010","unstructured":"Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li KT, Szeto CC. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss. Ren Fail. 2010;32(3):372\u20139.","journal-title":"Ren Fail"},{"issue":"3","key":"3471_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ajh.2008.360","volume":"22","author":"G Wang","year":"2009","unstructured":"Wang G, Lai FM, Kwan BC, Lai KB, Chow KM, Li PK, Szeto CC. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens. 2009;22(3):300\u20136.","journal-title":"Am J Hypertens"},{"issue":"11","key":"3471_CR10","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1093\/ndt\/gfs313","volume":"27","author":"A Fukuda","year":"2012","unstructured":"Fukuda A, Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC. Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Nephrol Dial Transplant. 2012;27(11):4079\u201387.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3471_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.kint.2020.03.038","volume":"98","author":"AS Naik","year":"2020","unstructured":"Naik AS, Le D, Aqeel J, Wang SQ, Chowdhury M, Walters LM, Cibrik DM, Samaniego M, Wiggins RC. Podocyte stress and detachment measured in urine are related to mean arterial pressure in healthy humans. Kidney Int. 2020;98(3):699\u2013707.","journal-title":"Kidney Int"},{"issue":"9","key":"3471_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3471_CR13","first-page":"83","volume":"39","author":"I Kostovska","year":"2020","unstructured":"Kostovska I, Tosheska-Trajkovska K, Topuzovska S, Cekovska S, Spasovski G, Kostovski O, Labudovic D. Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. J Med Biochem. 2020;39(1):83\u201390.","journal-title":"J Med Biochem"},{"key":"3471_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-62703-453-1_17","volume":"1024","author":"G Wang","year":"2013","unstructured":"Wang G, Szeto CC. Methods of microRNA quantification in urinary sediment. Methods Mol Biol. 2013;1024:211\u201320.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"3471_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/dmrr.2654","volume":"31","author":"G Wang","year":"2015","unstructured":"Wang G, Lai FM, Chow KM, Kwan BC, Pang WF, Luk CC, Leung CB, Li PK, Szeto CC. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy. Diabetes Metab Res Rev. 2015;31(7):699\u2013706.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"3471_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40620-022-01269-1","volume":"35","author":"A Jiang","year":"2022","unstructured":"Jiang A, Song A, Zhang C. Modes of podocyte death in diabetic kidney disease: an update. J Nephrol. 2022;35(6):1571\u201384.","journal-title":"J Nephrol"},{"issue":"1","key":"3471_CR17","doi-asserted-by":"publisher","first-page":"18209","DOI":"10.1038\/s41598-020-75320-1","volume":"10","author":"A Fukuda","year":"2020","unstructured":"Fukuda A, Minakawa A, Kikuchi M, Sato Y, Nagatomo M, Nakamura S, Mizoguchi T, Fukunaga N, Shibata H, Naik AS, Wiggins RC, Fujimoto S. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy. Sci Rep. 2020;10(1):18209.","journal-title":"Sci Rep"},{"issue":"15","key":"3471_CR18","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1073\/pnas.0511324103","volume":"103","author":"A Rojek","year":"2006","unstructured":"Rojek A, F\u00fcchtbauer EM, Kwon TH, Fr\u00f8kiaer J, Nielsen S. Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A. 2006;103(15):6037\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3471_CR19","doi-asserted-by":"publisher","first-page":"F1491","DOI":"10.1152\/ajprenal.00004.2013","volume":"305","author":"L Zhou","year":"2013","unstructured":"Zhou L, Liu G, Jia Z, Yang KT, Sun Y, Kakizoe Y, Liu M, Zhou S, Chen R, Yang B, Yang T. Increased susceptibility of db\/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters. Am J Physiol Renal Physiol. 2013;305(10):F1491\u20137.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3471_CR20","doi-asserted-by":"publisher","first-page":"107805","DOI":"10.1016\/j.diabres.2019.107805","volume":"155","author":"C Gao","year":"2019","unstructured":"Gao C, Zhang W. Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy. Diabetes Res Clin Pract. 2019;155:107805.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03471-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:04:23Z","timestamp":1706090663000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03471-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3471"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03471-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Joint Chinese University of Hong Kong\u2013 New Territories East Cluster Clinical Research Ethics Committee (approval number CREC-2016.480). All patients gave written informed consent. All study procedures were in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no other conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"32"}}